These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1511044)

  • 21. Effect of bicarbonate-based dialysis solutions on intracellular pH (pHi) and TNFalpha production by peritoneal macrophages.
    Rogachev B; Hausmann MJ; Yulzari R; Weiler M; Holmes C; Faict D; Chaimovitz C; Douvdevani A
    Perit Dial Int; 1997; 17(6):546-53. PubMed ID: 9655153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts.
    Kristensen SR; Pedersen FB
    Nephrol Dial Transplant; 1993; 8(2):163-7. PubMed ID: 8384339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bicarbonate/lactate dialysis solution on the inflammatory response of spontaneous peritonitis in rats undergoing chronic peritoneal dialysis.
    Pawlaczyk K; Holmes CJ; Czekalski S; Breborowicz A; Lindholm B
    Blood Purif; 2009; 28(3):200-8. PubMed ID: 19648739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of amphotericin B in CAPD fluid.
    Janknegt R; Paulissen A; Hooymans PM; Lohman JJ; Hermens WA
    Perit Dial Int; 1990; 10(4):287-9. PubMed ID: 2096930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
    Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
    Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
    Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
    Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialysate leaks in peritoneal dialysis.
    Leblanc M; Ouimet D; Pichette V
    Semin Dial; 2001; 14(1):50-4. PubMed ID: 11208040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients?
    Coles GA; Minors SJ; Horton JK; Fifield R; Davies M
    Perit Dial Int; 1989; 9(1):69-72. PubMed ID: 2488186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios.
    Schambye HT; Pedersen FB; Christensen HK; Berthelsen H; Wang P
    Perit Dial Int; 1993; 13 Suppl 2():S116-8. PubMed ID: 8399544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study.
    Pajek J; Kveder R; Bren A; Gucek A; Ihan A; Osredkar J; Lindholm B
    Perit Dial Int; 2008; 28(1):44-52. PubMed ID: 18178947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High serum D-lactate in patients on continuous ambulatory peritoneal dialysis.
    Anderson YS; Curtis NJ; Hobbs JA; Thompson CH; Winearls CG; Radda GK; Clarke K; Altmann P
    Nephrol Dial Transplant; 1997 May; 12(5):981-3. PubMed ID: 9175054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects on the peritoneal membrane of rabbits of a single bicarbonate solution containing glycylglycine.
    Yatzidis H
    Adv Perit Dial; 1994; 10():251-5. PubMed ID: 7999839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of nutritional status on CAPD peritonitis.
    Lee HY; Kim YK; Kang SW; Lee HW; Choi KH; Han DS
    Yonsei Med J; 1990 Mar; 31(1):65-70. PubMed ID: 2346041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.
    Topley N; Kaur D; Petersen MM; Jörres A; Passlick-Deetjen J; Coles GA; Williams JD
    Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
    Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
    Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Fischer FP; Schenk U; Kiefer T; Hübel E; Thomas S; Yatzidis H; Mettang T; Kuhlmann U
    Am J Kidney Dis; 1995 Dec; 26(6):924-33. PubMed ID: 7503067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is heparin therapy necessary in CAPD peritonitis?
    Nadig C; Binswanger U; von Felten A
    Perit Dial Int; 1997; 17(5):493-6. PubMed ID: 9358532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biocompatibility studies with bicarbonate-based solutions.
    Pedersen FB
    Adv Perit Dial; 1994; 10():245-50. PubMed ID: 7999838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
    Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
    Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis.
    Yamamoto T; Sakakura T; Yamakawa M; Horiuchi N; Hirata S; Iritani Y; Nishitani H; Kim M; Kishimoto T; Chiku T
    Nephron; 1992; 60(3):324-9. PubMed ID: 1565185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.